Digital pathology and lipid droplet size as a key determinant of discrepancies between histology and MRI gradings in steatotic liver disease - Summary - MDSpire

Digital pathology and lipid droplet size as a key determinant of discrepancies between histology and MRI gradings in steatotic liver disease

  • By

  • David Marti-Aguado

  • Clara Alfaro-Cervello

  • Matías Fernández-Patón

  • Amadeo Ten-Esteve

  • Leonor Cerdá-Alberich

  • Ana Crespo

  • Irene Navarrete-Pérez

  • María Pilar Ballester

  • Alexandre Perez-Girbes

  • Cristina Montón

  • Judith Pérez-Rojas

  • Víctor Puglia

  • Antonio Ferrández

  • Victoria Aguilera

  • Desamparados Escudero-García

  • Salvador Benlloch

  • Ana Jimenez-Pastor

  • Ángel Alberich-Bayarri

  • Claude B. Sirlin

  • Luis Marti-Bonmati

  • August 8, 2025

  • 0 min

Share

Objective:

To assess the relationship between the size distribution of lipid droplets (LDs) and discrepancies in steatosis grading as determined by histology and MRI-PDFF in patients with chronic liver disease, highlighting the clinical significance of these discrepancies.

Key Findings:
  • Discrepancies exist between histological and MRI-PDFF steatosis grading, which may impact treatment decisions.
  • Tiny and small LDs are often overlooked in histological assessments, potentially leading to underestimation of steatosis.
  • Digital pathology may offer a more accurate quantification of steatosis, suggesting a shift in standard practices.
Interpretation:

The size distribution of lipid droplets may significantly influence the grading of steatosis, highlighting the need for improved assessment techniques in clinical practice to enhance diagnostic accuracy.

Limitations:
  • Study limited to a specific cohort and may not generalize to all populations; future studies should include diverse demographics.
  • Potential biases in histological evaluation due to subjective scoring; implementing standardized training for pathologists could mitigate this.
Conclusion:

Digital pathology and detailed analysis of lipid droplet size could bridge the gap between histological and MRI assessments of steatosis, enhancing the accuracy of liver disease evaluations and ultimately improving patient outcomes.

Original Source(s)

Related Content